Skip to Main Content

Paper Details

Repurposing FDA-Approved Drugs for Temozolomide-Resistant IDH1 Mutant Glioma Using High-Throughput Miniaturized Screening on Droplet Microarray Chip.
0
2023
Author NameAffiliation
Christel Herold-MendeNeurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg
  • 1 - 1

Datasets

Release 1.2